MedPath

Predictors of Respiratory Failure in SARS-Cov-2 Infection

Conditions
SARS-CoV-2 Pneumonia
Registration Number
NCT04316949
Lead Sponsor
University of Bologna
Brief Summary

The emergence of SARS-CoV-2 is currently engaging and consuming most of resources of efficient healthcare systems in Europe, and several hospitals are currently experiencing a shortage of ICU beds for critically-ill patients with SARS-CoV-2 pneumonia.

A risk stratification based on clinical, radiological and laboratory parameters seems necessary in order to better identify those patients who may need ICU admission and/or those who may benefit from a prompt antiviral therapy

Detailed Description

The study will compared patients with and without respiratory failure in order to find risk factors for need for ICU admission. A simple score based on risk factors will be created from a multicenter Italian cohort and validated in a multicenter international cohort.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
350
Inclusion Criteria
  • Hospitalized patients with microbiologically confirmed diagnosis of SARS-CoV-2 infection
  • Age > 17 years
Exclusion Criteria
  • Invasive mechanical ventilation within 12 hours from hospital admission

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Respiratory failure14 days

Composite of ICU admission or SpO2\<92% with 100% FiO2 of oxygen treatment (reservoir mask or CPAP or NIV), respiratory rate \>30 bpm, respiratory distress

Secondary Outcome Measures
NameTimeMethod
Occurence of bacterial superinfection14 days

Incidence of bacterial superinfection among ventilated patients with SARS-CoV-2 pneumonia

Trial Locations

Locations (1)

University of Bologna - Department of Medical and Surgical Sciences

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath